Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 15

CoinDCX completes $135m series D round

Coinbase Ventures helped the cryptocurrency exchange increase its valuation to $2.15bn in a round pushing its overall funding past $240m.

Apr 19, 2022

Be Biopharma hauls in $130m

Takeda and Bristol Myers Squibb were among the investors that helped the cellular medicine developer close its series B round.

Apr 19, 2022

Waresix grows series B to near $124m

The logistics services provider has added $50m to its latest round, which is already backed by SoftBank, Emtek, Oko Markets and EV Growth.

Apr 19, 2022

Analysis: Nova Labs raised $200m

Several corporate venture investors participated in a round which took the crypto IoT network developer's valuation to $1.2bn. The round and the company are part of the larger crypto tech space, which has been attracting much interest and capital in most recent times.

Apr 18, 2022

Gaojing gathers $251m in series A funding

Aiko Solar and Midea Capital were among the participants in a round which will support ongoing construction of Gaojing's solar wafer production facility.

Apr 14, 2022

OSF Digital uploads $100m

Salesforce Ventures returned for a series C round which will support an ongoing acquisition spree for the digital transformation services provider.

Apr 14, 2022

Voyager Innovations sails to $210m

SIG Venture Capital led a round also backed by Tencent and PLDT that will help the mobile financial services provider launch additional products for its neobank.

Apr 13, 2022

Pax8 tacks on $185m

SoftBank Vision Fund 2 led a round for cloud software marketplace Pax8 that included Liberty Global Ventures at a $1.7bn valuation.

Apr 13, 2022

Observe.AI calls in $125m series C

The AI-powered call centre technology developer raised fresh capital in a round led by SoftBank Vision Fund 2 that also featured Zoom, Next47 and NGP Capital.

Apr 13, 2022

Aurion Biotech advances with $120m

Alcon was among the participants in a round representing the first funding to be disclosed by the cellular ophthalmology therapeutics developer.

Apr 13, 2022
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here